OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	105
Editorial Board	82
Editorial Board	79
Surgery for prolactinoma	72
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	69
Thiazide-induced hyponatremia	67
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	59
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	58
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	46
The role of androgens in transgender medicine	44
Sexual health and contraception in the menopause journey	42
Coronavirus disease 2019 and vitamin D	39
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	39
Editorial Board	37
Haematological actions of androgens	36
Impulse control disorders and dopamine agonists	36
Editorial Board	34
Cardiometabolic outcomes of early onset hypogonadism in males	34
Remnant lipoprotein particles and cardiovascular disease risk	29
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	28
Radioiodine therapy in the different stages of differentiated thyroid cancer	27
Editorial Board	27
Metabolic complications and their mechanisms in patients with craniopharyngioma	27
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	26
Epidemiology and risk factors for hypopituitarism due to traumatic brain injury	26

Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia	25
Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk	25
Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms	25